Imdylltra
Analogs of Imdylltra
Find cheaper analogs and generic equivalents for Imdylltra.
Active Ingredient: tarlatamab
Product Overview
About Imdylltra
Imdylltra is a prescription medicine that should be started and supervised by a doctor experienced in treating cancer.
What it is used for
There is no information available on what Imdylltra is used for.
How it is used
Imdylltra is given by infusion (drip) into a vein over 1 hour. The first two infusions are given one week apart, followed by one infusion every 2 weeks. Treatment can continue until the disease gets worse or side effects become unacceptable.
How it works
The active substance in Imdylltra, tarlatamab, is a T-cell engager, a type of antibody. Tarlatamab binds to two proteins: the DLL3 protein on cancer cells and the CD3 protein on T cells (a type of immune cell). This brings them close together and helps T cells recognise and kill the cancer cells.
Active substance: tarlatamab
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
